Navigation Links
AGA presents cutting-edge research during DDW®
Date:5/18/2012

b Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Pursuit SC (9:15 a.m. PT, Abstract #943d) William J. Sandborn et al.
  • Mudelta Treatment Improves Bowel Movement Frequency and Urgency Episodes in Patients With Diarrhea-Predominant Irritable Bowel Syndrome: Results of a Phase 2 Clinical Trial (9:30 a.m. PT, Abstract #943e) Paul S. Covington et al.
  • Tmc435 in HCV Genotype 1 Patients Who Have Failed Previous Pegylated Interferon/Ribavirin Treatment: Final Svr24 Results of the Aspire Trial (9:45 a.m. PT, Abstract #943f ) Fred Poordad et al.

    Plenary Sessions

    During the Presidential Plenary Session, AGA Institute President, C. Richard Boland, MD, AGAF, will focus on the latest research and clinical advances in the field of gastroenterology. Two additional plenary sessions feature noteworthy clinical and basic science research presented at DDW.

    The Presidential Plenary Session presentations (May 21, 10 a.m. PT, Room 20d) include:

    • The Future of Clinical Practice in Gastroenterology. John I. Allen, Minnesota Gastroenterology PA; University of Minnesota School of Medicine
    • Medicine in the United Kingdom - Contrasts and Lessons From the National Health Service. Jonathan M. Rhodes, University of Liverpool
    • Curing Chronic Viral Hepatitis - the New World of Antiviral Therapy. Jacqueline G. O'Leary, Liver Consultants of Texas
    • GI Motility, Irritable Bowel Syndrome, and Women. Lin Chang, UCLA Division of Digestive Diseases
    • The Future of Personalized Medicine - Reality vs Illusion. Anil K. Rustgi, University of Pennsylvania School of Medicine
    • How Will We Prevent Colorectal Cancer in the Future? Dennis J. Ahnen, Denver VA Medical Center
    • The Microbiome and Inflammation. Gary D. Wu, University of Pennsylvania School of Medicine
    • Obesity, Diet and the Microbiome. Lee M. Kaplan, Massachusetts General Hospital
    • The Future of IBD Therapy. William J. Sa
      '/>"/>

    Contact: Alissa Cruz
    media@gastro.org
    619-525-6241
    American Gastroenterological Association
    Source:Eurekalert

    Page: 1 2 3 4 5

    Related medicine news :

    1. FAB-HOMES™ Presents First Passive House Collection
    2. NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
    3. AADR presents honorary membership to Senator Tom Harkin
    4. UCLA Health System Presents: How to Successfully Implement a Clinical Portal
    5. Refine Dermatique Aesthetic Medical Team Presents Free Educational Event in Otsego, MN
    6. CNBC Presents 'Tom Brokaw Reports: BOOMER$!' on Thursday, March 4th at 9PM ET/PT
    7. Fifth Anniversary of Global Tobacco Control Treaty Presents Opportunity For U.S. Ratification and Leadership
    8. CareTech Solutions Presents Specialized Healthcare Call Center at HIMSS10
    9. Morehead Presents Webinar on "When Satisfaction Isn't Enough: Improving RN Engagement"
    10. Targeting leukemia cells gene addiction presents new strategy for treatment
    11. Keynote Speaker Presents Top Business Plan For Internal Communication Through Social Media
  • Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... iFitDress.com, a well-known wedding dress manufacturer and ... 16 cocktail dresses . Included in the new range ... all of these charming outfits are offered at deeply ... has promised that all of the sweet 16 cocktail ... worth mentioning that all of them are set according ...
    (Date:11/26/2014)... Alex Kramer HealthDay Reporter ... arthritis may be more likely to achieve remission if they ... The study found that those who were heaviest had almost ... lowered the odds of remission. "Medication for rheumatoid arthritis ... Susan Goodman, the study,s lead author and a rheumatologist at ...
    (Date:11/26/2014)... Steven Reinberg HealthDay Reporter ... are smoking cigarettes than ever, health officials said. In ... 21 percent in 2005 to 18 percent in 2013. That ... to 42.1 million, despite the increasing population, according to the ... However,"we still have a long way to go, and if ...
    (Date:11/26/2014)... NJ (PRWEB) November 26, 2014 ... Lourdes Cardiology have launched a partnership designed to ... rates for congestive heart failure (CHF) patients in ... Center staff and Lourdes Cardiology team will help ... and supervised protocols. This partnership pairs the Cardiac ...
    (Date:11/26/2014)... San Francisco, CA (PRWEB) November 26, 2014 ... to hanker after cheap deals on Black Friday, which signifies ... taken to clicking items into their shopping carts in the ... rowdy crowds. , This Friday is going to ... sales in a day, with an estimated $2.48 billion in ...
    Breaking Medicine News(10 mins):Health News:iFitDress.com: Trendy Sweet 16 Cocktail Dresses Unveiled 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3Health News:U.S. Adult Smoking Rate Drops to New Low: CDC 2Health News:U.S. Adult Smoking Rate Drops to New Low: CDC 3Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 2Health News:Advanced Heart Failure Recovery Program comes to Deptford Center for Rehabilitation and Healthcare 3Health News:2014 Best Friday Deals Revealed by Top10InAction 2
    ... representatives and surgical ... Colo., Sept. 6 Syndicom, the premier developer,of ... had,finalized a one-year agreement with DePuy Spine, a ... agreed to provide software and,consulting services to develop ...
    ... Cutters scores, more than $70,000 in funds and diapers for the state,s ... ... NORTH HAVEN, Conn., Sept. 6 BlueCare(R) Family Plan,the Medicaid (HUSKY) ... the completion of its two-month public,awareness campaign for the New Haven Diaper ...
    ... now been thoroughly screened in the hunt for the ... confirms previous hypotheses and turn the spotlight on entirely ... prestigious New England Journal of Medicine. , Rheumatoid arthritis ... one per cent of the population. Its causes are ...
    ... joint study by UCLA and the Rand Corp. shows that ... not consistently in that parents custody. , Researchers found that ... not in the HIV-infected parents custody at any time. , ... nationally representative sample of people in care for HIV infection ...
    ... 1 million Medicare patients develop pressure ulcers costing the ... system more than $10 billion ... 10th Annual International Pressure Ulcer Prevalence Survey (IPUPS) were,released by ... a leading provider of medical technology for hospitals and other,care ...
    ... ABAX ), a medical products company manufacturing point-of-care,blood ... will present at the CL King & Associates, Inc. ... 11:45 a.m. Eastern Time,at the Omni Berkshire Place Hotel ... develops, manufactures and markets portable blood analysis,systems for use ...
    Cached Medicine News:Health News:Syndicom to Launch Online Community for DePuy Spine 2Health News:BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank 2Health News:BlueCare(R) Family Plan, a HUSKY Health Plan from Anthem Blue Cross and Blue Shield in Connecticut, Raises Awareness, Funds and Diapers for New Haven Diaper Bank 3Health News:The genes involved in rheumatoid arthritis identified 2Health News:UCLA/RAND study shows that many children of HIV-positive parents are not in their custody 2Health News:Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey 2Health News:Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey 3Health News:Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey 4
    (Date:11/26/2014)... 25, 2014  goBalto, Inc., the leading provider of ... a winner of Red Herring,s Top 100 Global ... North America award in 2013, marking its emergence as ... Red Herring,s Top 100 Global list has become ... and entrepreneurs. Red Herring editors were among the first ...
    (Date:11/26/2014)... LOVELAND, Colo. , Nov. 25, 2014   Heska ... ; "Heska" or the "Company"), a provider of advanced ... Dr. Robert Grieve , Executive Chair, will attend The ... 11, 2014. The one-on-one conference will be held at The ... IL from 8 a.m. to 2:30 p.m. Please ...
    (Date:11/26/2014)... and LONDON , Nov. 25, ... AstraZeneca (NYSE: AZN ) today announced that AMAGINE-2 ... doses of brodalumab in more than 1,800 patients with moderate-to-severe ... Stelara ® (ustekinumab) and placebo at week 12. Brodalumab ... analysis group were each shown to be superior to Stelara ...
    Breaking Medicine Technology:goBalto Selected as a 2014 Red Herring Top 100 Global Company 2goBalto Selected as a 2014 Red Herring Top 100 Global Company 3Heska to Attend Benchmark Micro Cap Discovery Conference 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 2Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 3Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 4Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 5Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 6Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 7Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 8Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 9Amgen And AstraZeneca Announce Positive Results From Third And Final Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis 10
    ... Boston Medical Center (BMC) in ... long-awaited WASP® (Walk Away Specimen Processor), which includes ... with the inauguration of BMC,s new clinical laboratory ... care by consolidating resources and improving workflow within ...
    ... Siemens Healthcare (NYSE: SI)  has announced that ... system with a wireless detector, recently received 510(k) clearance ... is now commercially available in the U.S. The Mira,s ... and its unique rotating swivel arm helps increase ease ...
    Cached Medicine Technology:COPAN WASP® Lands at Prestigious Boston Medical Center 2COPAN WASP® Lands at Prestigious Boston Medical Center 3Siemens Mobilett Mira Mobile Digital X-Ray System Receives FDA Clearance 2
    Midstream Catch Kits...
    ... BVI 6100 is a handheld, noninvasive ultrasound ... easy to operate, so any staff member ... view ultrasound images from exams and print ... and reimbursement, just log on to ScanPoint®, ...
    ... Collagen Implant, the world's leading bulking therapy, ... the treatment of Stress Urinary Incontinence (SUI). ... urethral tissue to aid coaptation in a ... own structure, Contigen Bard Collagen Implant forms ...
    ... Positionable Penile Prosthesis,The AMS ... is made of cobalt-chrome ... strength that gives patients ... ease of positioning, cosmetic ...
    Medicine Products: